Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
- April -
May
-
June
-
July
-
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
April 2016 - 46 products
IP
CI
DorzoComp-Vision 20mg/ml /
5mg/ml
5 ml
12.37
29.90
10 %
Eye drops: 2 Active Agents
OmniVision AG
B / SL / SG
FB
G
IP
CI
DorzoComp-Vision 20mg/ml /
5mg/ml
3 x 5 ml
35.80
55.40
10 %
Eye drops: 2 Active Agents
OmniVision AG
B / SL / SG
FB
G
IP
CI
Duloxetin Sandoz 30 mg
28 Capsule(s)
10.46
27.80
10 %
magensaftresistente Hartkapseln: Duloxetinum 30 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin Sandoz 30 mg
84
26.67
45.60
10 %
magensaftresistente Hartkapseln: Duloxetinum 30 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin Sandoz 60 mg
14 Capsule(s)
9.72
26.95
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin Sandoz 60 mg
28 Capsule(s)
18.41
36.45
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin Sandoz 60 mg
84
53.75
74.95
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Sandoz
Pharmaceuticals AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin Zentiva 30 mg
28
10.46
27.80
10 %
magensaftresistente Hartkapseln: Duloxetinum 30 mg
Helvepharm AG
B / SL / SG
FB
G
IP
CI
Duloxetin Zentiva 60 mg
14 Capsule(s)
9.72
26.95
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin Zentiva 60 mg
28 Capsule(s)
18.41
36.45
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Helvepharm AG
● 
B / SL / SG
FB
G
IP
CI
Duloxetin Zentiva 60 mg
84
53.75
74.95
10 %
magensaftresistente Hartkapseln: Duloxetinum 60 mg
Helvepharm AG
● 
B / SL / SG
FB
G
L
IP
Nucala 100 mg
976.63
1078.55
10 %
Lyophilisate: Mepolizumabum 100 mg
GlaxoSmithKline AG
● 
B / SL
FB
G
L
IP
CI
Jinarc 15 mg
28
1288.92
1418.20
10 %
Tablets: Tolvaptanum 15 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
A / SL
FB
G
L
IP
CI
Jinarc 30 mg
28
1288.92
1418.20
10 %
Tablets: Tolvaptanum 30 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
A / SL
FB
G
L
IP
CI
Jinarc 45 mg + 15 mg
28 + 28
1288.92
1418.20
10 %
Tablets: Tolvaptanum 45 mg
Tablets: Tolvaptanum 15 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
A / SL
FB
G
L
IP
CI
Jinarc 60 mg + 30 mg
28 + 28
1288.92
1418.20
10 %
Tablets: Tolvaptanum 60 mg
Tablets: Tolvaptanum 30 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
A / SL
FB
G
L
IP
CI
Jinarc 90 mg + 30 mg
28 + 28
1288.92
1418.20
10 %
Tablets: Tolvaptanum 90 mg
Tablets: Tolvaptanum 30 mg
Otsuka Pharmaceutical
(Switzerland) GmbH
A / SL
FB
G
L
IP
CI
CM
Luvit D3 zur Prophylaxe
10 ml
2.31
4.25
10 %
Solution (oral): Cholecalciferolum 4000 UI/ml
Drossapharm AG
D / SL
FB
G
L
IP
CI
CM
Luvit D3 zur Therapie
30 ml
6.93
16.75
10 %
Solution (oral): Cholecalciferolum 4000 UI/ml
Drossapharm AG
B / SL
FB
G
IP
CI
Binosto 70 mg
4 Tablet(s)
17.42
35.30
10 %
Comprimés effervescents: Acidum Alendronicum 70 mg
Labatec Pharma SA
B / SL
FB
G
IP
CI
Binosto 70 mg
12
44.43
64.95
10 %
Comprimés effervescents: Acidum Alendronicum 70 mg
Labatec Pharma SA
B / SL
FB
G
L
IP
CI
PP
Praluent 75 mg
188.96
221.90
10 %
solution pour injection dans un stylo pré-rempli: Alirocumabum 75 mg/ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
CI
PP
Praluent 75 mg
2 Fertigspritze(n)
367.46
416.05
10 %
solution pour injection dans un stylo pré-rempli: Alirocumabum 75 mg/ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
L
IP
CI
PP
Praluent 150 mg
2 Fertigspritze(n)
367.46
416.05
10 %
solution pour injection dans un stylo pré-rempli: Alirocumabum 150 mg/ml
Sanofi-Aventis
(Suisse) SA
B / SL
FB
G
IP
Urapidil Stragen i.v. 25 mg
5 x 5 ml
PR
PR
k.A.
Injection solution: Urapidilum 25mg / 5ml
Stragen Pharma SA
B
FB
G
IP
Urapidil Stragen i.v. 50 mg
5 x 10 ml
PR
PR
k.A.
Injection solution: Urapidilum 50mg / 10ml
Stragen Pharma SA
B
FB
G
IP
CI
Glycerin ELK Pharma
18
PR
PR
k.A.
Suppositories: Glycerolum 2250 mg
mmpharm GmbH
D / LPPV
FB
G
IP
CI
CM
Coop Vitality Pantoprazol
14
PR
PR
k.A.
Coated tablets: Pantoprazolum 20 mg
Coop Vitality Health
Care GmbH
D
FB
G
IP
CI
CM
Dismenol Formel L forte
10
PR
PR
k.A.
Coated tablets: Ibuprofenum Lysinum 684 mg
Merz Pharma (Schweiz) AG
D
FB
G
IP
CI
Lisenia 30
21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Lisenia 30
3 x 21 Tablet(s)
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Lisenia 30
6 x 21
PR
PR
k.A.
Coated tablets: 2 Active Agents
Sandoz
Pharmaceuticals AG
B / LPPV
FB
G
IP
CI
Tadalafil-Mepha 2.5 mg
28
PR
PR
k.A.
Coated tablets: Tadalafilum 2.5 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 5 mg
28
PR
PR
k.A.
Coated tablets: Tadalafilum 5 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 5 mg
84
PR
PR
k.A.
Coated tablets: Tadalafilum 5 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 10 mg
4
PR
PR
k.A.
Coated tablets: Tadalafilum 10 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 10 mg
12
PR
PR
k.A.
Coated tablets: Tadalafilum 10 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 20 mg
4
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 20 mg
8
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 20 mg
12
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
Mepha Pharma AG
B
FB
G
IP
Tadalafil-Mepha 20 mg
24
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
Mepha Pharma AG
B
FB
G
IP
CI
CM
Luvit D3 zur Prophylaxe
20 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Drossapharm AG
D
FB
G
CI
Ph
Sidroga Erkältungstee N
20 x 2 g
PR
PR
k.A.
Arzneitee: 3 Active Agents
Uriach Switzerland AG
D
FB
G
IP
CI
Fung-X Nail
2.5 ml
PR
PR
k.A.
Nagellack: Amorolfinum 50 mg/ml
axapharm ag
D
FB
G
IP
CI
PP
Praluent 75 mg
6
PR
PR
k.A.
solution pour injection dans un stylo pré-rempli: Alirocumabum 75 mg/ml
Sanofi-Aventis
(Suisse) SA
B
FB
G
IP
CI
PP
Praluent 150 mg
6
PR
PR
k.A.
solution pour injection dans un stylo pré-rempli: Alirocumabum 150 mg/ml
Sanofi-Aventis
(Suisse) SA
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home